Skip Navigation


Human Molecular Genetics Advance Access originally published online on April 27, 2007
Human Molecular Genetics 2007 16(13):1578-1586; doi:10.1093/hmg/ddm107
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/13/1578    most recent
ddm107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Itoh, T.
Right arrow Articles by Linn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, T.
Right arrow Articles by Linn, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis

Toshiki Itoh1,*, Sachiyo Iwashita1, Michael B. Cohen1, David K. Meyerholz1 and Stuart Linn2

1 Department of Pathology, The University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA and 2 Department of Molecular and Cell Biology, University of California, Barker Hall, Berkeley, CA 94720, USA

* To whom correspondence should be addressed at: 1169ML, Department of Pathology, The University of Iowa, Newton Road, Iowa City, IA 52242, USA. Tel: +1 3193534235; Fax: +1 3193356559; Email: toshiki-ito{at}uiowa.edu

Received March 19, 2007; Accepted April 17, 2007

Damage-specific DNA-binding (DDB) protein heterodimer has been extensively studied in the context of nucleotide excision repair. However, the smaller subunit, DDB2, is also implicated in tumor suppressor p53-mediated processes, although the precise details of the DDB2 – p53 interactions are unknown. Here, we report that Ddb2–/– and Ddb2+/– mice have shortened lifespans and increased frequency and spectrum of spontaneous tumors. Notably, Ddb2 deficiency enhances lung and mammary adenocarcinomas. Ddb2–/– mice are smaller than normal. Whereas weights of kidneys and livers are reduced proportionately, spleens from Ddb2–/– mice gradually enlarge with age due to lymphoid proliferation. Ddb2–/– mice also have larger testes, and the testicular germ cells show significantly decreased spontaneous apoptosis. These changes parallel reduced levels of p53 and its serine 15 phosphorylation in testicular germ cells. Since tumors that appeared in heterozygous Ddb2+/– mice conserve the wild-type Ddb2 allele, Ddb2 RNA expression and Ddb2 exon sequence, Ddb2 heterozygosity can facilitate tumor development as a haploinsufficient tumor suppressor. These results demonstrate that in whole animals as in cultured cells Ddb2 can regulate apoptosis and tumor incidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.